NLM Logo

CAP-1 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
CAP-1 protocol
Unique ID
C083526
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C083526
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Cyclophosphamide
Doxorubicin / *analogs & derivatives
Frequency
10
Note
contains cyclophosphamide, pirarubicin & cisplatin; used in the therapy of recurrent adeno- and adenoidcystic carcinomas in the head & neck
Source
J Cancer Res Clin Oncol 1993;119(12):756-8
Date of Entry
1993/11/02
Revision Date
2013/11/06
CAP-1 protocol Preferred
page delivered in 0.004s